Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 30 70 years Diagnosed with Type 2 Diabetes Mellitus (as per ADA 2023 guidelines) HbA1c between 6.5% and 9.0% On stable oral hypoglycemic agents for at least 3 months Willing to replace dinner with study formulation Provided written informed consent
Exclusion criteria
Exclusion criteria: Insulin-dependent diabetics Chronic liver, kidney, thyroid dysfunction or cardiac diseases History of gastrointestinal disorders Allergy to millets or cereal grains Pregnant or lactating women Participation in other clinical trials in the last 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in HbA1c, FBS, PPBS, and OGTT response Change in vitamins (A, B2, B6, B12, D3) and microminerals (Magnesium, Calcium, Zinc, Phosphorus, Manganese, Copper, Selenium)Timepoint: Baseline (0th day) and Day 90 | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Liver Function Tests (LFT), Renal Function Tests (RFT), and Lipid profile (TC, LDL, HDL, TG) Change in hematological profile (CBC) and Quality of Life (QOL) using a validated diabetes-specific QOL scaleTimepoint: Baseline (oth day) and Day 90 | — |
Countries
India
Contacts
Pankajakasthuri Ayurveda Medical College and PG Centre